WS Data Solutions
Discounted Cash Flow Rating
Strong Buy
Return on Equity Rating
Strong Sell
Debt to Equity Rating
Sell
Price to Earnings Rating
Buy
Analyst Rating
Sell
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Standard Deviation
Sell
Williams %R
Strong Buy
Average Directional Index
Strong Sell
Insider Trading
Neutral
Wall Street Data Solutions Rating
Neutral
B
Revelation Biosciences, Inc. Common Stock (REVB)
Pharmaceutical Preparations
https://www.revbiosciences.com
Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease. It has several product candidates in development. REVTx-99, the lead therapeutic candidate, is an intranasal immunomodulator to prevent or treat infections caused by various respiratory viruses such as SARS-CoV-2, including its variants, influenza A and B, parainfluenza, rhinovirus, and RSV. REVTx-99 is also being developed for other indications such as: allergic rhinitis and chronic nasal congestion. REVTx-200 is an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for more complete immunity. REVTx-200 is based on the same technology used in REVTx-99.
4660 LAJOLLA VILLAGE DRIVE, SUITE 100
SAN DIEGO, CA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
01/11/2022
Market Cap
1,456,044
Shares Outstanding
6,300,000
Weighted SO
6,297,303
Total Employees
N/A
Upcoming Earnings
08/09/2024
Beta
0.2160
Last Div
0.0000
Range
0.81-28.2
Chg
-0.0080
Avg Vol
655385
Mkt Cap
1456044
Exch
NASDAQ
Country
US
Phone
650-800-3717
DCF Diff
-6.3851
DCF
9.7451
Div Yield
0.0000
P/S
38.7514
EV Multiple
1.1065
P/FV
1.2704
Div Yield %
0.0000
P/E
-0.0911
PEG
-0.0009
Payout
0.0000
Current Ratio
1.0961
Quick Ratio
1.0961
Cash Ratio
1.0848
DSO
0.0000
DIO
0.0000
Op Cycle
0.0000
DPO
17983.6536
CCC
-17983.6536
Gross Margin
0.3079
Op Margin
-253.5883
Pretax Margin
-423.2323
Net Margin
-423.2323
Eff Tax Rate
0.0058
ROA
-1.2961
ROE
-2.4391
ROCE
-8.3551
NI/EBT
1.0000
EBT/EBIT
1.6690
EBIT/Rev
-253.5883
Debt Ratio
0.0000
D/E
0.0000
LT Debt/Cap
0.0000
Total Debt/Cap
0.0000
Int Coverage
-1.2249
CF/Debt
0.0000
Equity Multi
10.7588
Rec Turnover
0.0000
Pay Turnover
0.0203
Inv Turnover
0.0000
FA Turnover
0.5309
Asset Turnover
0.0031
OCF/Share
-5.5259
FCF/Share
-5.5376
Cash/Share
7.3831
OCF/Sales
-240.4899
FCF/OCF
1.0021
CF Coverage
0.0000
ST Coverage
0.0000
CapEx Coverage
-471.3210
Div&CapEx Cov
-471.3210
P/BV
1.2704
P/B
1.2704
P/S
38.7514
P/E
-0.0911
P/FCF
-0.1608
P/OCF
-0.1603
P/CF
-0.1603
PEG
-0.0009
P/S
38.7514
EV Multiple
1.1065
P/FV
1.2704
DPS
0.0000
Latest Headlines (EST)
No Headlines Found